149 related articles for article (PubMed ID: 36280830)
21. Long-term outcomes by a transanal approach to total mesorectal excision for rectal cancer.
Marks JH; Myers EA; Zeger EL; Denittis AS; Gummadi M; Marks GJ
Surg Endosc; 2017 Dec; 31(12):5248-5257. PubMed ID: 28643051
[TBL] [Abstract][Full Text] [Related]
22. Molecular risk factors for locoregional recurrence in resected non-small cell lung cancer.
Guo W; Zhang T; Li R; Chen X; Pang J; Bao H; Wu X; Shao Y; Qiu B; Gao S; He J
Cancer Med; 2023 Jul; 12(14):15026-15036. PubMed ID: 37248810
[TBL] [Abstract][Full Text] [Related]
23. An observational study of patho-oncological outcomes of various surgical methods in total mesorectal excision for rectal cancer: a single center analysis.
Chen YT; Huang CW; Ma CJ; Tsai HL; Yeh YS; Su WC; Chai CY; Wang JY
BMC Surg; 2020 Feb; 20(1):23. PubMed ID: 32013990
[TBL] [Abstract][Full Text] [Related]
24. Local recurrence after mesorectal excision for rectal cancer.
Nesbakken A; Nygaard K; Westerheim O; Mala T; Lunde OC
Eur J Surg Oncol; 2002 Mar; 28(2):126-34. PubMed ID: 11884047
[TBL] [Abstract][Full Text] [Related]
25. Wait and see approach for rectal cancer with a clinically complete response after neoadjuvant concurrent chemoradiotherapy.
Kim HJ; Song JH; Ahn HS; Choi BH; Jeong H; Choi HS; Lee YH; Kang KM; Jeong BK
Int J Colorectal Dis; 2017 May; 32(5):723-727. PubMed ID: 27885479
[TBL] [Abstract][Full Text] [Related]
26. Organ preservation with chemoradiotherapy plus local excision for rectal cancer: 5-year results of the GRECCAR 2 randomised trial.
Rullier E; Vendrely V; Asselineau J; Rouanet P; Tuech JJ; Valverde A; de Chaisemartin C; Rivoire M; Trilling B; Jafari M; Portier G; Meunier B; Sieleznieff I; Bertrand M; Marchal F; Dubois A; Pocard M; Rullier A; Smith D; Frulio N; Frison E; Denost Q
Lancet Gastroenterol Hepatol; 2020 May; 5(5):465-474. PubMed ID: 32043980
[TBL] [Abstract][Full Text] [Related]
27. Survival analysis of local excision vs total mesorectal excision for middle and low rectal cancer in pT1/pT2 stage and intermediate pathological risk.
Lai IL; You JF; Chern YJ; Tsai WS; Chiang JM; Hsieh PS; Hung HY; Yeh CY; Chiang SF; Lai CC; Tang RP; Chen JS; Hsu YJ
World J Surg Oncol; 2019 Dec; 17(1):212. PubMed ID: 31818295
[TBL] [Abstract][Full Text] [Related]
28. Total Mesorectal Excision Versus Local Excision After Preoperative Chemoradiotherapy in Rectal Cancer With Lymph Node Metastasis: A Propensity Score-Matched Analysis.
Shin YS; Park JH; Yoon SM; Kim JC; Yu CS; Lim SB; Park IJ; Kim TW; Hong YS; Kim KP; Choi EK; Ahn SD; Lee SW; Kim JH
Int J Radiat Oncol Biol Phys; 2018 Jul; 101(3):630-639. PubMed ID: 29678529
[TBL] [Abstract][Full Text] [Related]
29. Post-relapse outcomes after primary extended resection of retroperitoneal sarcoma: A report from the Trans-Atlantic RPS Working Group.
MacNeill AJ; Miceli R; Strauss DC; Bonvalot S; Hohenberger P; Van Coevorden F; Rutkowski P; Callegaro D; Hayes AJ; Honoré C; Fairweather M; Cannell A; Jakob J; Haas RL; Szacht M; Fiore M; Casali PG; Pollock RE; Raut CP; Gronchi A; Swallow CJ
Cancer; 2017 Jun; 123(11):1971-1978. PubMed ID: 28152173
[TBL] [Abstract][Full Text] [Related]
30. [Effect of total mesorectal excision and preoperative chemoradiotherapy on local recurrence in rectal cancer].
Wu AW; Gu J; Wang J
Zhonghua Wei Chang Wai Ke Za Zhi; 2006 May; 9(3):207-9. PubMed ID: 16721678
[TBL] [Abstract][Full Text] [Related]
31. Comparison of Transanal Endoscopic Microsurgery and Total Mesorectal Excision in the Treatment of T1 Rectal Cancer: A Meta-Analysis.
Lu JY; Lin GL; Qiu HZ; Xiao Y; Wu B; Zhou JL
PLoS One; 2015; 10(10):e0141427. PubMed ID: 26505895
[TBL] [Abstract][Full Text] [Related]
32. The risk factors of local recurrence and distant metastasis on pT1/T2N0 mid-low rectal cancer after total mesorectal excision.
Lai IL; You JF; Chern YJ; Tsai WS; Chiang JM; Hsieh PS; Hung HY; Hsu YJ
World J Surg Oncol; 2021 Apr; 19(1):116. PubMed ID: 33849564
[TBL] [Abstract][Full Text] [Related]
33. Association of Plane of Total Mesorectal Excision With Prognosis of Rectal Cancer: Secondary Analysis of the CAO/ARO/AIO-04 Phase 3 Randomized Clinical Trial.
Kitz J; Fokas E; Beissbarth T; Ströbel P; Wittekind C; Hartmann A; Rüschoff J; Papadopoulos T; Rösler E; Ortloff-Kittredge P; Kania U; Schlitt H; Link KH; Bechstein W; Raab HR; Staib L; Germer CT; Liersch T; Sauer R; Rödel C; Ghadimi M; Hohenberger W;
JAMA Surg; 2018 Aug; 153(8):e181607. PubMed ID: 29874375
[TBL] [Abstract][Full Text] [Related]
34. Pathological complete response may underestimate distant metastasis in locally advanced rectal cancer following neoadjuvant chemoradiotherapy and radical surgery: Incidence, metastatic pattern, and risk factors.
Sun Y; Wu X; Zhang Y; Lin H; Lu X; Huang Y; Chi P
Eur J Surg Oncol; 2019 Jul; 45(7):1225-1231. PubMed ID: 30879932
[TBL] [Abstract][Full Text] [Related]
35. The outcome of rectal cancer after early salvage TME following TEM compared with primary TME: a case-matched study.
Levic K; Bulut O; Hesselfeldt P; Bülow S
Tech Coloproctol; 2013 Aug; 17(4):397-403. PubMed ID: 23192705
[TBL] [Abstract][Full Text] [Related]
36. Treatment of rectal cancer: reduction of local recurrence after the introduction of TME - experience from one University Hospital.
Bernardshaw SV; Øvrebø K; Eide GE; Skarstein A; Røkke O
Dig Surg; 2006; 23(1-2):51-9. PubMed ID: 16717469
[TBL] [Abstract][Full Text] [Related]
37. Selective approach for upper rectal cancer treatment: total mesorectal excision and preoperative chemoradiation are seldom necessary.
Marinello FG; Frasson M; Baguena G; Flor-Lorente B; Cervantes A; Roselló S; Espí A; García-Granero E
Dis Colon Rectum; 2015 Jun; 58(6):556-65. PubMed ID: 25944427
[TBL] [Abstract][Full Text] [Related]
38. Patterns of failure in patients with locally advanced rectal cancer receiving pre-operative or post-operative chemoradiotherapy.
Yeo SG; Kim MJ; Kim DY; Chang HJ; Kim MJ; Baek JY; Kim SY; Kim TH; Park JW; Oh JH
Radiat Oncol; 2013 May; 8():114. PubMed ID: 23647920
[TBL] [Abstract][Full Text] [Related]
39. Oncologic and survival outcomes in elderly patients with locally advanced rectal cancer receiving neoadjuvant chemoradiotherapy and total mesorectal excision.
He F; Chen M; Xiao WW; Zhang Q; Liu Y; Zheng J; Wan XB; Gao YH
Jpn J Clin Oncol; 2021 Aug; 51(9):1391-1399. PubMed ID: 34155513
[TBL] [Abstract][Full Text] [Related]
40. Comparison of transanal total mesorectal excision (TaTME) versus laparoscopic TME for rectal cancer: A case matched study.
Ye J; Tian Y; Li F; van Oostendorp S; Chai Y; Tuynman J; Tong W
Eur J Surg Oncol; 2021 May; 47(5):1019-1025. PubMed ID: 33309105
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
